- Home
- TAOP vs PHIO Comparison
TAOP vs PHIO Comparison
Compare TAOP & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- PHIO
- Stock Information
- Founded
- TAOP 1993
- PHIO 2011
- Country
- TAOP China
- PHIO United States
- Employees
- TAOP N/A
- PHIO N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- TAOP Technology
- PHIO Health Care
- Exchange
- TAOP Nasdaq
- PHIO Nasdaq
- Market Cap
- TAOP 2.5M
- PHIO 2.3M
- IPO Year
- TAOP N/A
- PHIO N/A
- Fundamental
- Price
- TAOP $0.36
- PHIO $2.21
- Analyst Decision
- TAOP
- PHIO Strong Buy
- Analyst Count
- TAOP 0
- PHIO 1
- Target Price
- TAOP N/A
- PHIO $36.00
- AVG Volume (30 Days)
- TAOP 750.2K
- PHIO 41.4K
- Earning Date
- TAOP 09-05-2024
- PHIO 11-14-2024
- Dividend Yield
- TAOP N/A
- PHIO N/A
- EPS Growth
- TAOP N/A
- PHIO N/A
- EPS
- TAOP 0.50
- PHIO N/A
- Revenue
- TAOP $42,636,173.00
- PHIO N/A
- Revenue This Year
- TAOP N/A
- PHIO N/A
- Revenue Next Year
- TAOP N/A
- PHIO N/A
- P/E Ratio
- TAOP $0.57
- PHIO N/A
- Revenue Growth
- TAOP 37.49
- PHIO N/A
- 52 Week Low
- TAOP $0.33
- PHIO $2.17
- 52 Week High
- TAOP $2.01
- PHIO $18.81
- Technical
- Relative Strength Index (RSI)
- TAOP 32.81
- PHIO 32.01
- Support Level
- TAOP $0.33
- PHIO $2.49
- Resistance Level
- TAOP $0.51
- PHIO $3.70
- Average True Range (ATR)
- TAOP 0.04
- PHIO 0.31
- MACD
- TAOP -0.00
- PHIO -0.10
- Stochastic Oscillator
- TAOP 20.00
- PHIO 2.75
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.